Business
Half-year Report
Half-year Report.
About this update from Smith & Nephew Plc
[{"type":"text","content":"\n\nSmith+Nephew Second Quarter and First Half 2024 Results\n12-Point Plan driving first half revenue growth, trading margin expansion and stronger cash flow. Full year guidance unchanged\n \n1 August 2024\n \nSmith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, reports results for the second quarter and first half ended 29 June 2024:\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n \n\n\n29 June \n\n\n \n\n\n1 July \n\n\n \n\n\nReported\n\n\n \n\n\nUnderlying\n\n\n\n\n \n\n\n \n\n\n2024\n\n\n \n\n\n2023\n\n\n \n\n\ngrowth\n\n\n \n\n\ngrowth\n\n\n\n\n \n\n\n \n\n\n$m\n\n\n \n\n\n$m\n\n\n \n\n\n%\n\n\n \n\n\n%\n\n\n\n\nSecond Quarter Results1,2\n\n\n \n\n\n \n\n\n \n\n\n \n\n\n \n\n\n \n\n\n \n\n\n \n\n\n\n\nRevenue\n\n\n \n\n\n1,441\n\n\n\n\n\n1,379\n\n\n\n\n\n 4.6\n\n\n\n\n\n 5.6\n\n\n\n\n\n\n\n \n\n\n \n\n\n \n\n\n \n\n\n \n\n\n \n\n\n \n\n\n \n\n\n\n\nHalf Year Results1,2\n\n\n \n\n\n \n\n\n \n\n\n \n\n\n \n\n\n \n\n\n \n\n\n \n\n\n\n\nRevenue\n\n\n\n\n\n2,827\n\n\n\n\n\n2,734\n\n\n\n\n\n 3.4\n\n\n\n\n\n 4.3\n\n\n\n\nOperating profit\n\n\n\n\n\n328\n\n\n\n\n\n275\n\n\n\n\n\n 19.5\n\n\n\n\n\n\n\n\n\n\nOperating profit margin (%)\n\n\n\n\n\n11.6\n\n\n\n\n\n10.0\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nEPS (cents)\n\n\n\n\n\n24.5\n\n\n\n\n\n19.7\n\n\n\n\n\n 24.6\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nTrading profit\n\n\n\n\n\n471\n\n\n\n\n\n417\n\n\n\n\n\n 12.8\n\n\n\n\n\n\n\n\n\n\nTrading profit margin (%)\n\n\n\n\n\n16.7\n\n\n\n\n\n15.3\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nEPSA (cents)\n\n\n\n\n\n37.6\n\n\n\n\n\n34.9\n\n\n\n\n\n 7.7\n\n\n\n\n\n\n\n\n\n\n \n \nQ2 Trading Highlights1,2\n· Q2 revenue of $1,441 million (Q2 2023: $1,379 million), up 5.6% (4.6% on a reported basis including -100bps FX headwind)\n· Orthopaedics revenue up 5.8% (4.9% reported), with good growth across Hip and Knee Implants outside the US, Other Reconstruction and Trauma & Extremities; further progress in addressing...